Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study

Haematologica

Volumn 90, Issue 7, 2005, Pages 990-992

  Oriol, Albert ^a   Ribera, Josep Maria ^b   Brunet, Salut ^b   Del Potro, Eloy ^b   Abella, Eugènia ^b   Esteve, Jordi ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b NONE

Author keywords

Burkitt's leukemia, HIV infection; Burkitt's lymphoma; HAART treatment, intensive chemotherapy

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENIPOSIDE; VINCRISTINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; INFECTION; LEUKEMIA; LIVER TOXICITY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; REMISSION; SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; LEUCOVORIN; LEUKEMIA; LYMPHOMA, AIDS-RELATED; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME; VINCRISTINE;

EID: 22544467810     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hoelzer D, Ludwig WD, Thiel E, Gassman W, Loffler H, Fonastch C, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996;87:495-508.
2. Cortes J, Thomas D, Rios A, Koller C, O'Brien S, Jeha S, et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 2002;94:1492-9.
3. Oriol A, Ribera JM, Esteve J, Sanz MA, Brunet S, Garcia-Boyero R, et al. Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica 2003;88:445-53.
4. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 2000;283:381-90.
5. Hoffmann C, Tabrizian S, Wolf E, Egger C, Stoehr A, Plettenberg A, et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001;15:2119-27.
6. Antinori A, Cingoiani A, Alba L, Ammassari A, Serraino D, Ciancio BC, et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483-91.